Chronic Fluoxetine Treatment Induces Brain Region-Specific Upregulation of Genes Associated with BDNF-Induced Long-Term Potentiation
Open accessThe DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Several lines of evidence implicate BDNF in the pathogenesis of stress-induced depression and the delayed efficacy of antidepressant drugs. Antidepressant-induced upregulation of BDNF signaling is thought to promote adaptive neuronal plasticity through effects on gene expression, but the effector genes downstream of BDNF has not been identified. Local infusion of BDNF into the dentate gyrus induces a long-term potentiation (BDNF-LTP) of synaptic transmission that requires upregulation of the immediate early gene Arc. Recently, we identified five genes (neuritin, Narp, TIEG1, Carp, and Arl4d) that are coupregulated with Arc during BDNF-LTP. Here, we examined the expression of these genes in the dentate gyrus, hippocampus proper, and prefrontal cortex after antidepressant treatment. We show that chronic, but not acute, fluoxetine administration leads to upregulation of these BDNF-LTP-associated genes in a brain region-specific pattern. These findings link chronic effects of antidepressant treatment to molecular mechanisms underlying BDNF-induced synaptic plasticity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In particular, antidepressant drugs rapidly activate TrkB signaling and gradually increase BDNF expression, and the behavioral effects of antidepressants are mediated by and dependent on BDNF signaling through TrkB at least in rodents.”
From Neuronal plasticity and neurotrophic factors in drug responses (2017) · cites this paper as [112]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Later, multiple studies reported that chronic antidepressant treatment increases Bdnf mRNA expression107–109 and triggers upregulation of genes associated with BDNF-induced plasticity110–112.”
From Neuronal plasticity and neurotrophic factors in drug responses (2017) · cites this paper as [112]
In the citing paper
“In addition, BDNF protein levels as well as the expression of genes associated with BDNF-induced plasticity are increased after chronic antidepressant treatment112,114.”
From Neuronal plasticity and neurotrophic factors in drug responses (2017) · cites this paper as [112]
In the citing paper
“In addition, BDNF protein levels as well as the expression of genes associated with BDNF-induced plasticity are increased after chronic antidepressant treatment112,114.”
From Neuronal plasticity and neurotrophic factors in drug responses (2017) · cites this paper as [112]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., & Speleman, F. (2002) · Genome Biology · doi:10.1186/gb-2002-3-7-research0034 · Cited by 20,038 · cited 1×
“The determination of an appropriate housekeeping gene is discussed in several papers [35].”
BackgroundA Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375 · cited 1×
“Antidepressant-induced upregulation of total (exon-V) BDNF mRNA expression has been observed in many studies, but the regional expression pattern varies with the antidepressant used and treatment paradigm, with some studies reporting no effect (reviewed in [15, 16]).”
BackgroundBrain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression
Shirayama, Y., Chen, A. C.-H., Nakagawa, S., Russell, D. S., & Duman, R. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03251.2002 · Cited by 1,654 · cited 1×
“Furthermore, acute infusion of BDNF into the dentate gyrus has behavioral antidepressant-like effects in rats [63].”
BackgroundNew approaches to antidepressant drug discovery: beyond monoamines
Berton, O., & Nestler, E. J. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1846 · Cited by 1,589 · cited 1×
“These brain regions were selected for analysis because of their role in memory loss and other cognitive features of affective disorders, and because chronic antidepressant treatment is thought to upregulate BDNF function in these regions [13].”
BackgroundBDNF function in adult synaptic plasticity: The synaptic consolidation hypothesis
Bramham, C. R., & Messaoudi, E. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.06.003 · Cited by 1,193 · cited 1×
“One of the major regulators of LTP consolidation is the secretory polypeptide brain-derived neurotrophic factor (BDNF) [2, 3].”
BackgroundSelf-citationThe Sp-family of transcription factors
Suske, G. (1999) · Gene · doi:10.1016/s0378-1119(99)00357-1 · Cited by 1,107 · cited 1×
“These transcription factors bind to GC-rich elements in the promoter region of target genes and are known to regulate a large number of genes involved in cell growth, differentiation and apoptosis [26, 39, 40].”
BackgroundSaarelainen, T., Hendolin, P., Lucas, G., Koponen, E., Sairanen, M., MacDonald, E., Agerman, K., Haapasalo, A., Nawa, H., Aloyz, R., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-01-00349.2003 · Cited by 800 · cited 1×
“A single injection of fluoxetine, although sufficient to activate TrkB receptors [20], does not induce enhanced expression of BDNF-LTP-coupled genes.”
BackgroundYing, S.-W., Futter, M., Rosenblum, K., Webber, M. J., Hunt, S. P., Bliss, T. V. P., & Bramham, C. R. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01532.2002 · Cited by 784 · cited 1×
“Recently, we identified five genes (neuritin, Narp, TIEG1, Carp, and Arl4d) that are coupregulated with Arc during BDNF-LTP.”
BackgroundSelf-citationEssential role of brain-derived neurotrophic factor in adult hippocampal function
Monteggia, L. M., Barrot, M., Powell, C. M., Berton, O., Galanis, V., Gemelli, T., Meuth, S., Nagy, A., Greene, R. W., & Nestler, E. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402141101 · Cited by 685 · cited 1×
“Copyright © 2007 Maria Nordheim Alme et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.”
MethodRole of neurotrophic factors in depression
CASTREN, E., VOIKAR, V, & RANTAMAKI, T. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.08.009 · Cited by 667 · cited 1×
“Antidepressant-induced upregulation of total (exon-V) BDNF mRNA expression has been observed in many studies, but the regional expression pattern varies with the antidepressant used and treatment paradigm, with some studies reporting no effect (reviewed in [15, 16]).”
Background
Research works printed but not linked: 1
- Ying S-W Futter M Rosenblum K Brain-derived neurotrophic factor induces long-term potentiation in intact adult hippocampus: requirement for ERK activation coupled to CREB and upregulation of Arc synthesis The Journal of Neuroscience 2002 22 5 1532 1540 11880483 PMC6758896 · DOI · Paper page
Cited by
Brunoni, A. R., Lopes, M., & Fregni, F. (2008) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009309 · Cited by 972
“Preclinical studies show that antidepressant increases BDNF expression in rats and cell cultures (Alme et al., 2007; Balu et al., 2008; Henkel et al., 2008).”
BackgroundBramham, C. R., Alme, M. N., Bittins, M., Kuipers, S. D., Nair, R. R., Pai, B., Panja, D., Schubert, M., Soule, J., Tiron, A., et al. (2010) · Experimental Brain Research · doi:10.1007/s00221-009-1959-2 · Cited by 452
“Interestingly, the BDNF-regulated genes exhibited a region-speciWc pattern of upregulation in the prefrontal cortex, hippocampus, and dentate gyrus, after chronic (but not acute) treatment with the SSRI Xuoxetine (Alme et al. 2007).”
BackgroundSelf-citationNeuronal plasticity and neurotrophic factors in drug responses
Castrén, E., & Antila, H. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.61 · Cited by 284
Alboni, S., van Dijk, R. M., Poggini, S., Milior, G., Perrotta, M., Drenth, T., Brunello, N., Wolfer, D. P., Limatola, C., Amrein, I., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2015.142 · Cited by 207
Cavalleri, L., Merlo Pich, E., Millan, M. J., Chiamulera, C., Kunath, T., Spano, P. F., & Collo, G. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.241 · Cited by 156
Wibrand, K., Panja, D., Tiron, A., Ofte, M. L., Skaftnesmo, K., Lee, C. S., Pena, J. T. G., Tuschl, T., & Bramham, C. R. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07112.x · Cited by 140
“Samples were assayed in triplicate and normalized to polyubiquitine (Alme et al., 2007).”
MethodSelf-citationSakharkar, A. J., Vetreno, R. P., Zhang, H., Kokare, D. M., Crews, F. T., & Pandey, S. C. (2016) · Brain Structure and Function · doi:10.1007/s00429-016-1196-y · Cited by 122
“BDNF contributes to synaptic plasticity as well as NPC survival and differentiation (Duman and Monteggia 2006; Alme et al. 2007).”
The role of neurotrophins in major depressive disorder
Jiang, C., & Salton, S. (2013) · Translational Neuroscience · doi:10.2478/s13380-013-0103-8 · Cited by 113
Functional role of KLF10 in multiple disease processes
Subramaniam, M., Hawse, J. R., Rajamannan, N. M., Ingle, J. N., & Spelsberg, T. C. (2010) · BioFactors · doi:10.1002/biof.67 · Cited by 115
“KLF10 expression is induced in response to the action of brain derived neurotrophic factor [70], in response to GDNF (glial cell line-derived neutrotrophic factor) [19,71], and to nerve growth factor [72].”
Mice with altered BDNF signaling as models for mood disorders and antidepressant effects
Lindholm, J. S. O., & Castrén, E. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00143 · Cited by 114
“Although a large number of models have been employed and several studies have been published, no clear-cut connections between BDNF levels or signaling and depression-like behavior in mice have emerged.”
BackgroundA comprehensive network and pathway analysis of candidate genes in major depressive disorder
Jia, P., Kao, C.-F., Kuo, P.-H., & Zhao, Z. (2011) · BMC Systems Biology · doi:10.1186/1752-0509-5-s3-s12 · Cited by 104
“55 × 10 ) are involved in neuron/brain tissues and have been reported to be involved in MDD [53,54].”
BackgroundLyons, L., ElBeltagy, M., Umka, J., Markwick, R., Startin, C., Bennett, G., & Wigmore, P. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2122-2 · Cited by 109
“These results are supported by rodent investigations showing fluoxetine increases levels of brain-derived neurotrophic factor (BDNF; Alme et al. 2007; Duman and Monteggia 2006), the rate of neurogenesis (Chen et al.”
BackgroundResultInfluentialSon, H., Banasr, M., Choi, M., Chae, S. Y., Licznerski, P., Lee, B., Voleti, B., Li, N., Lepack, A., Fournier, N. M., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201191109 · Cited by 103
“Moreover, chronic antidepressant treatment has been shown to increase neuritin expression in rat brain (21).”
BackgroundMicroRNA Regulation of the Synaptic Plasticity-Related Gene Arc
Wibrand, K., Pai, B., Siripornmongcolchai, T., Bittins, M., Berentsen, B., Ofte, M. L., Weigel, A., Skaftnesmo, K. O., & Bramham, C. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041688 · Cited by 96
“(HRPT) or the geometric mean of polyubiqutin, HRPT and cyclophilin [44].”
BackgroundSelf-citationHu, Y., Yang, J., Yu-ping, H., Wang, Y., & Li, W. (2010) · European Journal of Anaesthesiology · doi:10.1097/eja.0b013e328331a3d5 · Cited by 98
Depression and antidepressants: molecular and cellular aspects
Lanni, C., Govoni, S. M., Lucchelli, A., & Boselli, C. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0055-x · Cited by 107
“Exogenous application of BDNF, which induces a long-term potentiation (BDNF-LTP) [225], required upregulation of the immediate early gene Arc [226] and five other genes regulated with Arc during BDNF-LTP; moreover, an upregulation of these BDNF-LTP-associated genes only after chronic antidepressant administration has…”
BackgroundPilar-Cuéllar, F., Vidal, R., Díaz, A., Castro, E., dos Anjos, S., Pascual-Brazo, J., Linge, R., Vargas, V., Blanco, H., Martínez-Villayandre, B., et al. (2013) · Neural Plasticity · doi:10.1155/2013/537265 · Cited by 90
Lyons, L., ELBeltagy, M., Bennett, G., & Wigmore, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030010 · Cited by 90
“Fluoxetine may be acting by increasing the level of brainderived neurotrophic factor (BDNF) [43,44] [45] and indirectly affecting neurogenesis or by directly increasing the proliferation of hippocampal neural stem cells [46].”
BackgroundNeuropeptides in depression: Role of VGF
Thakker-Varia, S., & Alder, J. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.10.006 · Cited by 86
Otto, M. W., McHugh, R. K., & Kantak, K. M. (2010) · Clinical Psychology Science and Practice · doi:10.1111/j.1468-2850.2010.01198.x · Cited by 87
Therapeutic Advances and Future Prospects in Progressive Forms of Multiple Sclerosis
Shirani, A., Okuda, D. T., & Stüve, O. (2016) · Neurotherapeutics · doi:10.1007/s13311-015-0409-z · Cited by 93
“of the production of the brain-derived neurotrophic factor in animal models [57–59].”
BackgroundLydiatt, W. M. (2013) · JAMA Otolaryngology–Head & Neck Surgery · doi:10.1001/jamaoto.2013.3371 · Cited by 82
Klf10 and Klf11 as mediators of TGF-beta superfamily signaling
Spittau, B., & KRIEGLSTEIN, K. G. (2011) · Cell and Tissue Research · doi:10.1007/s00441-011-1186-6 · Cited by 84
“An investigation by the same Table 2 Overview of inductive cues for Klf10 and Klf11 in diverse cell types and tissues group has further demonstrated the upregulation of Klf10 after chronic treatment of rats with the antidepressant Fluoxetine by a mechanism that probably involves Bdnf (Alme et al. 2007).”
BackgroundInfluentialLi, Y., Pehrson, A. L., Waller, J. A., Dale, E., Sánchez, C., & Gulinello, M. E. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00279 · Cited by 84
“Alme et al. (2007) found that acute 10mg/kg fluoxetine failed to alter Arc expression in the prefrontal cortex, hippocampus and dentate gyrus, but after 21 days Arc expression was significantly increased in the prefrontal cortex and hippocampus.”
BackgroundMolecular Mechanisms of Synaptic Dysregulation in Fragile X Syndrome and Autism Spectrum Disorders
Telias, M. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00051 · Cited by 82
Molecular Mechanisms Underlying Memory Consolidation of Taste Information in the Cortex
Gal-Ben-Ari, S., & Rosenblum, K. (2012) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2011.00087 · Cited by 81
“…has been described in several brain areas, including the hippocampus and the cortex, and in conjunction with taste learning, (Escobar et al., 1998, 2002; Ramirez-Lugo et al., 2003; Chen et al., 2006; Alme et al., 2007; Bramham, 2007; McGeachie et al., 2011; Rodriguez-Duran et al., 2011).”
BackgroundEckert, M. J., & Abraham, W. C. (2012) · Current topics in behavioral neurosciences · doi:10.1007/7854_2012_215 · Cited by 91
“Interestingly, antidepressant medications as well as EE/exercise increase BDNF levels, particularly in the hippocampus (Alme et al. 2007; Falkenberg et al. 1992; Farmer et al. 2004).”
BackgroundA Review of Modern Antidepressants Effects on Neurocognitive Function
Biringer, E., Rongve, A., & Lund, A. (2009) · Current Psychiatry Reviews · doi:10.2174/157340009788971137 · Cited by 73
“Newer research indicates that BDNF may mediate the increase in neurogenesis that takes place during use of antidepressant medication [9, 49-51].”
BackgroundSeo, M. K., Lee, C. H., Cho, H. Y., Lee, J. G., Lee, B. J., Kim, J. E., Seol, W., Kim, Y. H., & Park, S. W. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.11.019 · Cited by 68
Chronic treatment with fluoxetine prevents the return of extinguished auditory-cued conditioned fear
Deschaux, O., Spennato, G., Moreau, J., & Garcia, R. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2134-y · Cited by 67
“Third, chronic fluoxetine treatment favors induction and maintenance of synaptic potentiation in the hippocampal–prefrontal cortex pathway (Alme et al. 2007; Rocher et al. 2004).”
BackgroundLi, C., Meng, F., Lei, Y., Liu, J., Liu, J., Zhang, J., Liu, F., Liu, C., Guo, M., & Lu, X. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-00922-0 · Cited by 65
“For example, tranylcypromine and desipramine increase exon I, II, and IV (original III) mRNAs, fluoxetine treatment enhances activity of promoter II [88], whereas reboxetine increases activation of promoter IV [87].”
BackgroundCoppens, C. M., Siripornmongcolchai, T., Wibrand, K., Alme, M. N., Buwalda, B., de Boer, S. F., Koolhaas, J. M., & Bramham, C. R. (2011) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2011.00072 · Cited by 61
“Treatment with antidepressant drugs triggers enhanced BDNF gene expression and signaling that is required for the restorative behavioral effects in animal models of depression (Alme et al., 2007; Rantamaki et al., 2007; Adachi et al., 2008).”
InfluentialSelf-citationEnhanced cognitive function and antidepressant-like effects after krill oil supplementation in rats
Wibrand, K., Berge, K., Messaoudi, M., Duffaud, A. M., Panja, D., Bramham, C. R., & Burri, L. (2013) · Lipids in Health and Disease · doi:10.1186/1476-511x-12-6 · Cited by 62
“tex of rodents subjected to behavioural stress but enhanced following treatment with antidepressant drugs [19-25].”
BackgroundSelf-citationDaniele, S., Da Pozzo, E., Zappelli, E., & Martini, C. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.04.006 · Cited by 56
“A significant decrease in the expression of CREB and BDNF was also observed, which is consistent with decreases in these neurotrophic factors in stress-induced animal models of depression [10,14-16,56].”
BackgroundResultMechanisms of antidepressant action: An integrated dopaminergic perspective
Porcelli, S., Drago, A., Fabbri, C., & Serretti, A. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.03.005 · Cited by 58
Szewczyk, B., Pochwat, B., Muszyńska, B., Opoka, W., Krakowska, A., Rafało-Ulińska, A., Friedland, K., & Nowak, G. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112045 · Cited by 51
Betancur, D. F. A., Tarragó, M. D. G. L., Torres, I. L. D. S., Fregni, F., & Caumo, W. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.678198 · Cited by 55
“In addition, in a study by Kuan et al. (39), aberrant neuronal activity in the pathway between the medial thalamus and cingulate cortex, having the brain-derived neurotrophic factor (BDNF) as a mediator, was observed.”
BackgroundNeuritin, A Neurotrophic Factor in Nervous System Physiology
Zhou, S., & Zhou, J. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666131218093327 · Cited by 51
“Neuritin mRNA expression increased at different levels in the prefrontal cortex, hippocampus proper, and dentate gyrus with a brain region-specific pattern [50].”
Backgroundde Bartolomeis, A., Buonaguro, E. F., Latte, G., Rossi, R., Marmo, F., Iasevoli, F., & Tomasetti, C. (2017) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2017.00240 · Cited by 44
“Moreover, IEGs have been found to be modulated also by other psychotropic drugs, such as antidepressants (De Foubert et al., 2004; Alme et al., 2007; Molteni et al., 2008; Calabrese et al., 2011), mood stabilizers (De Bartolomeis et al., 2012), as well as by the combination of antipsychotics and…”
BackgroundAntidepressive Effects of Environmental Enrichment in Chronic Stress–Induced Depression in Rats
Seong, H., Park, J., & Kim, Y. (2017) · Biological Research For Nursing · doi:10.1177/1099800417730400 · Cited by 47
Lee, L. H.-W., Shui, G., Farooqui, A. A., Wenk, M. R., Tan, C.-H., & Ong, W.-Y. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114570900995x · Cited by 43
“…which showed behavioural changes in animal models (Parra et al. 2000 ; Pinhasov et al. 2005 ; Reneric et al. 2001 ; Shirayama et al. 2002) as well as neurochemical changes (Alme et al. 2007 ; Laakso et al. 1996 ; Martinez-Turrillas et al. 2002 ; Tan et al. 2006) after antidepressant administration.”
BackgroundHippocampal BDNF signaling restored with chronic asiaticoside treatment in depression-like mice
Luo, L., Liu, X., Mu, R.-H., Wu, Y.-J., Liu, B., Geng, D., Liu, Q., & Yi, L. (2015) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2015.03.006 · Cited by 43
Kroeze, Y., Peeters, D. G. A., Boulle, F., van den Hove, D., van Bokhoven, H., Zhou, H., & Homberg, J. R. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.145 · Cited by 40
Licata, S. C., Shinday, N. M., Huizenga, M. N., Darnell, S. B., Sangrey, G. R., Rudolph, U., Rowlett, J. K., & Sadri‐Vakili, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0084806 · Cited by 39
“g004 drug action in general [45-47] and processes related to abuse”
Liu, J. X., Pinnock, S. B., & Herbert, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017562 · Cited by 36
“It is known that BDNF is increased by fluoxetine [18], and that this seems essential for increased progenitor mitosis [15].”
BackgroundRogóż, Z., Skuza, G., & Legutko, B. (2008) · PubMed · Cited by 41
Impact of Neuritin 1 ( NRN1 ) polymorphisms on fluid intelligence in schizophrenia
Chandler, D., Dragović, M., Cooper, M. N., Badcock, J. C., Mullin, B. H., Faulkner, D., Wilson, S. G., Hallmayer, J. F., Howell, S., Rock, D. J., et al. (2009) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30996 · Cited by 38
“, 2006] and was recently shown to be among the BDNF-regulated genes whose expression increases following chronic antidepressant treatment [Alme et al., 2007].”
BackgroundInfluentialWu, S., Guo, Y., Jiang, S., Wei, L., Liu, Z., Wang, X., & Su, Y. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2552-5 · Cited by 34
Wang, Y., Xiao, Z., Liu, X., & Berk, M. (2011) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1177 · Cited by 36
“Chronic antidepressant administration can up-regulate the expression of BDNF mRNA and synaptic plasticity in multiple cerebral regions (Alme et al., 2007).”
BackgroundNPTX2 is a key component in the regulation of anxiety
Chang, S., Bok, P., Tsai, C., Sun, C., Liu, H., Deussing, J. M., & Huang, G. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0091-z · Cited by 34
Cline, B. H., Costa-Nunes, J. P., Cespuglio, R., Васильева, Н. А., Santos, A. I., Bukhman, Y. V., Kubatiev, A. A., Steinbusch, H. W. M., Lesch, K., & Strekalova, T. V. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00037 · Cited by 31
Herbert, J., Ban, M., Brown, G. W., Harris, T. O., Ogilvie, A., Uher, R., & Craig, T. K. J. (2012) · British Journal of Psychiatry · doi:10.1192/bjp.bp.111.107037 · Cited by 24
Kroeze, Y., Peeters, D. G. A., Boulle, F., van den Hove, D., van Bokhoven, H., Zhou, H., & Homberg, J. R. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.60 · Cited by 28
Samuels, B. A., Leonardo, E. D., Dranovsky, A., Williams, A., Wong, E. H. F., Nesbitt, A. M. I., McCurdy, R. D., Hen, R., & Alter, M. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085136 · Cited by 29
“treatment responses[30,31,32,33], was identified in this cluster.”
BackgroundLyttle, K., Ohmura, Y., Konno, K., Yoshida, T., Izumi, T., Watanabe, M., & Yoshioka, M. (2015) · Brain Research · doi:10.1016/j.brainres.2015.04.058 · Cited by 26
Bentefour, Y., Rakibi, Y., Bennis, M., Ba-M’hamed, S., & Garcia, R. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.12.021 · Cited by 26
“Interestingly, likewise successful extinction, chronic SSRI treatment favors induction and maintenance of prefrontal synaptic potentiation (Rocher et al., 2004; Alme et al., 2007).”
Welbat, J. U., Sangrich, P., Sirichoat, A., Chaisawang, P., Chaijaroonkhanarak, W., Prachaney, P., Pannangrong, W., & Wigmore, P. M. (2016) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2016.09.003 · Cited by 25
Prats, C., Arias, B., Ortet, G., Ibáñez, M. I., Moya-Higueras, J., Pomarol‐Clotet, E., Fañanás, L., & Fatjó‐Vilas, M. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.11.017 · Cited by 25
“2012), whereas electroconvulsive therapy and antidepressant treatment produced changes in Neuritin levels (Alme et al. 2007; Dyrvig et al. 2014).”
BackgroundTikhonova, M. A., & Kulikov, A. V. (2012) · The Chinese Journal of Physiology · doi:10.4077/cjp.2012.baa041 · Cited by 24
“that: [1] BDNF is effective in the treatment of some genetically defined behavioral disturbances; [2] BDNF”
BackgroundIn vivo and in vitro effects of vortioxetine on molecules associated with neuroplasticity
Kugathasan, P., Waller, J. A., Westrich, L., Abdourahman, A., Tamm, J. A., Pehrson, A. L., Dale, E., Gulinello, M. E., Sánchez, C., & Li, Y. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116667710 · Cited by 23
“1 expression in young male rodents (Alme et al., 2007), vortioxetine does not increase BDNF at the mRNA level in hippocampal (Li et al., 2015a) or in frontal cortical (results not shown) homogenate in middle-aged female mice.”
BackgroundVakhitova, Y. V., Kalinina, T. S., Zainullina, L. F., Lusta, A. Y., Volkova, A. V., Kudryashov, N. V., Gudasheva, T. A., Shimshirt, A. A., Kadnikov, I. A., Voronin, M. V., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413381 · Cited by 21
Santoro, M., Nociti, V., Fino, C. D., Caprara, A. L. F., Giordano, R., Palomba, N. P., Losavio, F. A., Marra, C., Patanella, A. K., Mirabella, M., et al. (2016) · European Journal of Neurology · doi:10.1111/ene.12913 · Cited by 21
Tate, K. M., Kirk, B., Tseng, A., Ulffers, A. E., & Litwa, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910457 · Cited by 20
Rajamanickam, G., Lee, A. T.-H., & Liao, P. (2024) · Neurochemical Research · doi:10.1007/s11064-024-04175-z · Cited by 19
Dringenberg, H. C., Day, L. R. B., & Choi, D. H. (2014) · Neural Plasticity · doi:10.1155/2014/571285 · Cited by 19
Satvat, E., Gheidi, A., Voll, S., Odintsova, I. V., & Marrone, D. F. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.11.025 · Cited by 18
“Although previous data have shown that chronic fluoxetine does not alter constitutive expression levels of activity-related genes such as Arc within the DG (Alme et al., 2007), the potential still remains that fluoxetine may augment activity-induced levels of these proteins, particularly given data that fluoxetine tre…”
BackgroundBjartmar, L., Alkhori, L., Ruud, J., Mohammed, A. H. S., Marcusson, J. O., & Hallbeck, M. (2010) · Brain Research · doi:10.1016/j.brainres.2010.03.004 · Cited by 16
Milnacipran Remediates Impulsive Deficits in Rats with Lesions of the Ventromedial Prefrontal Cortex
Tsutsui‐Kimura, I., Yoshida, T., Ohmura, Y., Izumi, T., & Yoshioka, M. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu083 · Cited by 17
“However, previous studies show inconsistent effects of SSRIs on impulsive action (Evenden, 1999; Tsutsui-Kimura et al., 2009; Baarendse and Vanderschuren, 2012; Humpston et al., 2013), suggesting that the acute effects of SSRIs on impulsive action are weaker than those of other impulsivity-suppressing agents.”
ResultInfluentialConnor, D. A., & Gould, T. J. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.07.033 · Cited by 15
“In addition, FLX is known to increase brain derived neurotrophic factor (BDNF) gene expression in the PFC and hippocampus (Alme et al., 2007).”
BackgroundLim, S.-H., Shin, S., Kim, M., Kim, E. C., Lee, D. Y., Moon, J., Park, H.-Y., Ryu, Y., Kang, Y.-M., Kang, Y. J., et al. (2020) · Journal of Cell Science · doi:10.1242/jcs.243972 · Cited by 15
Gao, Y., Yao, Y., Liang, X., Tang, J., Ma, J., Qi, Y., Huang, C., Zhang, Y., Chen, L., Chao, F., et al. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.11.013 · Cited by 13
Tkachev, A., Stekolshchikova, E., Bobrovskiy, D. M., Anikanov, N. A., Ogurtsova, P., Park, D. I., Horn, A. K. E., Petrova, D., Khrameeva, E. E., Golub, M. S., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158089 · Cited by 13
Li, C.-C., & Lee, F.-J. S. (2010) · AfCS-Nature Molecule Pages · doi:10.1038/mp.a003973.01 · Cited by 11
Jetsonen, E., Didio, G., Suleymanova, I., Teino, I., Ċastrén, E., & Umemori, J. (2025) · Neuropsychopharmacology · doi:10.1038/s41386-025-02219-8 · Cited by 12
G-protein coupled receptors and synaptic plasticity in sleep deprivation
Parmar, S., Tadavarty, R., & Sastry, B. R. (2021) · World Journal of Psychiatry · doi:10.5498/wjp.v11.i11.954 · Cited by 11
Emerging drugs for primary progressive multiple sclerosis
Narayan, R., Forsthuber, T. G., & Stüve, O. (2018) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2018.1463370 · Cited by 11
“tor (BDNF) from astrocytes and may improve cerebral blood flow by dilating cerebral arterioles independent of the endothelium [83].”
BackgroundEffect of pharmacological manipulations on Arc function
Yakout, D. W., Ramesh, N. S., & Mabb, A. M. (2020) · Current Research in Pharmacology and Drug Discovery · doi:10.1016/j.crphar.2020.100013 · Cited by 11
Shukkoor, M. S. A., Baharuldin, M. T. H., Jais, A. M. M., Moklas, M. A. M., Fakurazi, S., & Basir, R. (2017) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2017/1469209 · Cited by 11
Shin, E., Jeong, J. H., Chung, Y. H., Kim, T., Shin, C. Y., Kim, W., Ko, K. H., & Kim, H. (2009) · Journal of Pharmacological Sciences · doi:10.1254/jphs.09015sc · Cited by 8
Heinrich, I. A., Freitas, A. E., Wolin, I. A. V., Nascimento, A. P. M., Walz, R., Rodrigues, A. L. S., & Leal, R. B. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00675-x · Cited by 8
“Concerning this set of results, it is fundamental to highlight that each brain region exhibits a unique gene expression pattern after chronic antidepressant treatment (Alme et al. 2007).”
BackgroundMonje, F. J., Kim, E., Cabatic, M., Lübec, G., Herkner, K. R., & Pollak, D. D. (2011) · Annals of Medicine · doi:10.3109/07853890.2010.538716 · Cited by 9
Shimada, T., Kohyama, K., Yoshida, T., & Yamagata, K. (2024) · Journal of Neuroscience · doi:10.1523/jneurosci.0129-23.2024 · Cited by 7
Kumamoto, H., Yamaguchi, T., Konno, K., Izumi, T., Yoshida, T., Ohmura, Y., Watanabe, M., & Yoshioka, M. (2017) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2017.12.002 · Cited by 6
A salience hypothesis of stress in PTSD
Chakraborty, P., Chattarji, S., & Jeanneteau, F. D. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15526 · Cited by 5
Würz, A., & Sungur, M. Z. (2009) · Psychiatry and Clinical Psychopharmacology · Cited by 7
Schuler, H., Zhou, D., Savignac, C., Cvetkovska, V., Tse, Y.-C., Meccia, J., Lopez, J., Harutyunyan, A. S., Ragoussis, J., Bzdok, D., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.08.631940 · Cited by 5
“In L5/6 NP, psilocybin upregulated Shank3 , a synaptic scaffold implicated in autism, schizophrenia and anxiety, also implicated in antidepressant response 69–71 as well as Nrn1 , an activity synaptic plasticity regulator also implicated in antidepressant response 72 .”
Rogóż, Z., & Skuza, G. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70150-1 · Cited by 6
Is a Combination of Pharmacotherapy and Psychotherapy Superior to Each Alone?
Choi, K., & Kim, Y. (2017) · Springer eBooks · doi:10.1007/978-981-10-6577-4_21 · Cited by 4
Chiba, S., Asano, H., Moriya, S., Hatakeyama, T., Kobayashi, S., Ohta, R., & Kawaguchi, M. (2023) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12313 · Cited by 3
NeuropsychopharmARCology: Shaping Neuroplasticity through Arc/ Arg3.1 Modulation
Mottarlini, F., Caffino, L., Fumagalli, F., Calabrese, F., & Brivio, P. (2024) · Current Neuropharmacology · doi:10.2174/011570159x338335240903075655 · Cited by 3
“1 mRNA levels in the hippocampus, with a not significant trend toward an increase in the PFC [105].”
Hodes, G. E., & Russo, S. J. (2012) · Royal Society of Chemistry eBooks · doi:10.1039/9781849734943-00159 · Cited by 2
Effect of fluoxetine treatment on neurotoxicity induced by lysolecithin in male rats
Gholami, E., Gholami, M., Tavakoli, A., Ahmadi, M., Rezaian, J., Alipour, M., Chehelcheraghi, F., & Khaksarian, M. (2021) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2021-0077 · Cited by 2
Assessment of anti-depressant activity of omega 3 fatty acids in rodents
Syed, A. A., & Chandra, K. V. (2018) · International Journal of Basic & Clinical Pharmacology · doi:10.18203/2319-2003.ijbcp20184845 · Cited by 1
“Chronic fluoxetine treatment was also found to induce brain region-specific upregulation of genes associated with BDNF induced long term potentiation.(18) This mechanism may not explain the observations of enhanced anti-depressant action of the omega-3 fatty acid and fluoxetine combination seen in the present study, a…”
BackgroundAlmodóvar-Payá, C., París-Gómez, I., Latorre-Guardia, M., Guardiola-Ripoll, M., Catalán, R., Arias, B., Penadés, R., & Fatjó‐Vilas, M. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111175 · Cited by 1
Factor neurotrófico derivado del cerebro en tejido cerebral de ratas sanas
Sánchez, T. S., Pedré, L. L., Rosado, J. B., Almaguer‐Melian, W., Lopez‐Rojas, J., Alberti‐Amador, E., Armesto, I. D., & León, J. F. M. (2009) · Revista CENIC. Ciencias biológicas
Development of aggression and impulsivity: Modulation by adolescent social stress?
Coppens, C. M. (2013) · University of Groningen research database (University of Groningen / Centre for Information Technology)
Insulin receptor sensitization improves affective pathology in various mouse models
Nunes, J. P. D. C. A. V. (2015) · Research Publications (Maastricht University) · doi:10.26481/dis.20151221jc
Almodóvar-Payá, C., Guardiola-Ripoll, M., Gallego, C., Callado, L. F., Giralt‐López, M., Latorre-Guardia, M., Salgado‐Pineda, P., Canales-Rodríguez, E. J., Miret, S., Fañanás, L., et al. (2022) · Neuroscience Applied · doi:10.1016/j.nsa.2022.100675
Shi, Y., Sprooten, E., Mulders, P. C. R., Vrijsen, J. N., van Eijndhoven, P., Tendolkar, I., Franke, B., & Mota, N. R. (2022) · Neuroscience Applied · doi:10.1016/j.nsa.2022.100674
Endogenous Biosynthesis and Neural Correlates of N,N-dimethyltryptamine
Glynos, N. G. (2023) · Deep Blue (University of Michigan) · doi:10.7302/8314
Metadata
- Authors
- Alme, M. N., Wibrand, K., Dagestad, G., & Bramham, C. R.
- Affiliations
- University of Bergen (NO)
- Corresponding author
- Bramham, Clive R.
- Venue
- Neural Plasticity
- Publisher
- Wiley
- Published
- 2007
- Volume
- 2007
- Pages
- 1-9
- ISSN
- 1687-5443 (ISSN-L)
- 2090-5904
- PMC
- PMC2248427
- OpenAlex
- W1995360320
- Cited by
- 103
- References
- 62
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 5 · 2023: 1 · 2021: 8 · 2020: 3 · 2019: 2 · 2018: 5 · 2017: 8 · 2016: 7 · 2015: 10 · 2014: 4 · 2013: 7 · 2012: 8
- FWCI
- 4.68
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Neural Plasticity (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- The Research Council (504231)
- Marie Curie Research Training Networks (504231)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- fluoxetine, brain-derived neurotrophic factor, long-term potentiation, Arc, neuritin, NARP, TIEG1, carp, antidepressant efficacy, stress-induced depression, synaptic plasticity, hippocampus, dentate gyrus, prefrontal cortex, gene expression, brain region specificity
- MeSH terms
- Pentraxins, Animals, Brain, C-Reactive Protein, Carrier Proteins, Depressive Disorder, DNA-Binding Proteins, Drug Administration Schedule, Drug Resistance, Fluoxetine, Gene Expression Regulation, Male, Nerve Tissue Proteins, Neuropeptides, Phosphoproteins, Stress, Psychological, Time Factors, Transcription Factors, Up-Regulation, Selective Serotonin Reuptake Inhibitors, Long-Term Potentiation, Brain-Derived Neurotrophic Factor, ADP-Ribosylation Factors, Rats, GPI-Linked Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.